Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Effect of variations in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in nondiabetic subjects

H Rosolova, O Jr Mayer, G Reaven

. 1997 ; 82 (11) : 3783-3785.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu práce podpořená grantem, Research Support, U.S. Gov't, P.H.S.

Perzistentní odkaz   https://www.medvik.cz/link/bmc14043550

Grantová podpora
IZ2617 MZ0 CEP - Centrální evidence projektů

Eighteen nondiabetic volunteers were selected for these studies on the basis of their plasma magnesium (Mg) concentrations defined as being either high (> 0.83 mmol/L) or low (< 0.80 mmol/L). Although different in Mg concentration (0.90 +/- 0.02 vs. 0.73 +/- 0.01 mmol/L), the 2 groups were comparable in terms of age, gender distribution, body mass index, and waist to hip girth. Measurements were made of their plasma glucose and insulin concentrations in response to a 75-g oral glucose load and the steady state plasma insulin and glucose (SSPG) concentrations at the end of an 180-min infusion of octreotide, insulin, and glucose. The low Mg group had significantly higher plasma glucose (P < 0.001) and insulin (P < 0.002) concentrations after the oral glucose challenge. Although the steady state plasma insulin concentrations were similar during the infusion study, the SSPG concentration was significantly (P < 0.001) greater in the low Mg group (11.9 +/- 0.9 vs. 6.6 +/- 0.9 mmol/L). Finally, when the 18 patients were analyzed together, there were significant (P < 0.05 to P < 0.01) inverse correlations between Mg concentrations and glucose (r = -0.68) and insulin (r = -0.51) areas and SSPG concentrations (r = -0.60). Thus, a low Mg concentration in nondiabetic subjects was associated with relative insulin resistance, glucose intolerance, and hyperinsulinemia.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14043550
003      
CZ-PrNML
005      
20170427090806.0
007      
ta
008      
140127s1997 xxud f 000 0|eng||
009      
AR
024    7_
$a 10.1210/jcem.82.11.4370 $2 doi
035    __
$a (PubMed)9360541
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Rosolová, Hana, $d 1954- $7 jn20000402132 $u Department of Internal Medicine, Medical Faculty, Charles University Pilsen, Czech Republic.
245    10
$a Effect of variations in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in nondiabetic subjects / $c H Rosolova, O Jr Mayer, G Reaven
520    9_
$a Eighteen nondiabetic volunteers were selected for these studies on the basis of their plasma magnesium (Mg) concentrations defined as being either high (> 0.83 mmol/L) or low (< 0.80 mmol/L). Although different in Mg concentration (0.90 +/- 0.02 vs. 0.73 +/- 0.01 mmol/L), the 2 groups were comparable in terms of age, gender distribution, body mass index, and waist to hip girth. Measurements were made of their plasma glucose and insulin concentrations in response to a 75-g oral glucose load and the steady state plasma insulin and glucose (SSPG) concentrations at the end of an 180-min infusion of octreotide, insulin, and glucose. The low Mg group had significantly higher plasma glucose (P < 0.001) and insulin (P < 0.002) concentrations after the oral glucose challenge. Although the steady state plasma insulin concentrations were similar during the infusion study, the SSPG concentration was significantly (P < 0.001) greater in the low Mg group (11.9 +/- 0.9 vs. 6.6 +/- 0.9 mmol/L). Finally, when the 18 patients were analyzed together, there were significant (P < 0.05 to P < 0.01) inverse correlations between Mg concentrations and glucose (r = -0.68) and insulin (r = -0.51) areas and SSPG concentrations (r = -0.60). Thus, a low Mg concentration in nondiabetic subjects was associated with relative insulin resistance, glucose intolerance, and hyperinsulinemia.
536    __
$c Grant Number: HL-08506 (United States NHLBI NIH HHS)
590    __
$a bohemika - dle Pubmed
650    02
$a dospělí $7 D000328
650    02
$a senioři $7 D000368
650    12
$a krevní glukóza $x metabolismus $7 D001786
650    02
$a ženské pohlaví $7 D005260
650    12
$a genetická variace $7 D014644
650    02
$a glukózový toleranční test $7 D005951
650    02
$a lidé $7 D006801
650    02
$a inzulin $x krev $7 D007328
650    12
$a inzulinová rezistence $7 D007333
650    12
$a hořčík $x krev $7 D008274
650    02
$a mužské pohlaví $7 D008297
650    02
$a lidé středního věku $7 D008875
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a Research Support, U.S. Gov't, P.H.S. $7 D013487
700    1_
$a Mayer, Otto, $d 1969- $7 xx0053346
700    1_
$a Reaven, Gerald M., $d 1928-2018 $7 xx0213049
773    0_
$t The journal of clinical endocrinology and metabolism $x 0021-972X $g Roč. 82, č. 11 (1997), s. 3783-3785 $p J Clin Endocrinol Metab $w MED00002582
910    __
$a ABA008 $b A 560 $y 4 $z 0
990    __
$a 20140127092436 $b ABA008
991    __
$a 20170427091126 $b ABA008
999    __
$a ok $b bmc $g 1008271 $s 842078
BAS    __
$a 3
BMC    __
$a 1997 $b 82 $c 11 $d 3783-3785 $x MED00002582 $i 0021-972X $m The Journal of clinical endocrinology and metabolism $n J Clin Endocrinol Metab
GRA    __
$a IZ2617 $p MZ0
LZP    __
$a NLK 2014-01/lpbo

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...